BioSpace News Archive

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, reported today its first quarter financial results ending March 31, 2021.

The increasing number of government funding and investments used for intense research and development activities for medical diagnostics is expected to boost the growth of the global single-cell analysis market during the forecast period 2020 to 2030.

Multiparameter patient monitoring market is expected to remain under the influence of increasing demographic of an ageing population, increasing adoption of advanced technologies in the healthcare sector and increasing emphasis on improving critical patient care settings.

BioSyent Inc. will be reporting its financial results for the three months ended March 31, 2021 on Thursday, May 27, 2021 at 8:00am EDT.

Entera Bio Ltd., a leader in the development of orally delivered large molecule therapeutics, announced financial and operating results for the quarter ended March 31, 2021.

Pharmaceutical industry veteran brings more than 20 years of business and technical operations experience across various commercial and development products

New Executives Bring Decades of Healthcare Industry Experience and Knowledge of the Nitric Oxide Market to Beyond Air in Preparation for Launch of LungFit® PH in the US

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, is pleased to announce that data from its TACTI-002 and INSIGHT-004 studies have been published in abstracts available via the links below on the 2021 American Society of Clinical Oncology’s (ASCO) 2021 Annual Meeting’s official website.

AbbVie (NYSE: ABBV) will participate in the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial officer, and Jeffrey R. Stewart , executive vice president, commercial operations, will present

ATI Physical Therapy, one of the nation’s largest providers of outpatient physical therapy services, reported financial results for the first quarter of 2021 ended March 31, 2021.